5.13
price up icon5.12%   0.25
pre-market  Pre-mercato:  5.08   -0.05   -0.97%
loading
Precedente Chiudi:
$4.88
Aprire:
$4.82
Volume 24 ore:
666.72K
Relative Volume:
2.53
Capitalizzazione di mercato:
$79.38M
Reddito:
-
Utile/perdita netta:
$-5.98M
Rapporto P/E:
-14.24
EPS:
-0.3603
Flusso di cassa netto:
$-9.83M
1 W Prestazione:
+7.55%
1M Prestazione:
+26.04%
6M Prestazione:
+69.87%
1 anno Prestazione:
+122.08%
Intervallo 1D:
Value
$4.70
$5.18
Intervallo di 1 settimana:
Value
$4.32
$5.18
Portata 52W:
Value
$1.75
$5.18

Grace Therapeutics Inc Stock (GRCE) Company Profile

Name
Nome
Grace Therapeutics Inc
Name
Telefono
609-322-1602
Name
Indirizzo
103 CARNEGIE CENTER, PRINCETON
Name
Dipendente
6
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
GRCE's Discussions on Twitter

Compare GRCE vs VRTX, REGN, ARGX, ALNY, INSM

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
GRCE icon
GRCE
Grace Therapeutics Inc
5.13 79.38M 0 -5.98M -9.83M -0.3603
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
438.71 111.45B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
761.85 80.54B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
746.42 46.32B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
318.85 42.29B 3.71B 313.75M 465.38M 2.2571
INSM icon
INSM
Insmed Inc
162.43 35.01B 606.42M -1.28B -997.58M -6.403

Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-02 Iniziato TD Cowen Buy
2020-09-01 Downgrade Oppenheimer Outperform → Perform
2020-07-06 Aggiornamento B. Riley FBR Neutral → Buy
2020-01-13 Downgrade B. Riley FBR Buy → Neutral
2019-08-29 Iniziato B. Riley FBR Buy
2019-07-18 Iniziato Oppenheimer Outperform
2019-06-26 Iniziato H.C. Wainwright Buy
Mostra tutto

Grace Therapeutics Inc Borsa (GRCE) Ultime notizie

pulisher
Apr 04, 2026

We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate - Yahoo Finance

Apr 04, 2026
pulisher
Apr 02, 2026

Replimune, Grace among biotechs with April PDUFA dates - biocentury.com

Apr 02, 2026
pulisher
Mar 31, 2026

GRCE Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 31, 2026
pulisher
Mar 31, 2026

GRCE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 31, 2026
pulisher
Mar 30, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Bull Run: Does MITK align with a passive investing strategy2026 Historical Comparison & Daily Chart Pattern Signals - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 26, 2026

HOTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 26, 2026
pulisher
Mar 26, 2026

What is Grace Therapeutics Incs valuation compared to sectorJobs Report & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

AI Investing InsightsOfficial HomepageIntellectia AI™ - intellectia.ai

Mar 26, 2026
pulisher
Mar 26, 2026

CELZ Technical Analysis & Price Forecast - Intellectia AI

Mar 26, 2026
pulisher
Mar 26, 2026

VUZI Technical Analysis & Price Forecast - Intellectia AI

Mar 26, 2026
pulisher
Mar 26, 2026

ZYXI Technical Analysis & Price Forecast - Intellectia AI

Mar 26, 2026
pulisher
Mar 25, 2026

Short Interest in Grace Therapeutics, Inc. (NASDAQ:GRCE) Grows By 300.8% - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Analyst Upgrade: How much upside does New Fortress Energy Inc haveWeekly Investment Recap & Low Risk Entry Point Tips - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

DG Technical Analysis & Price Forecast - intellectia.ai

Mar 24, 2026
pulisher
Mar 23, 2026

PUGBY News & Events - Intellectia AI

Mar 23, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Grace Therapeutics, Inc (GRCE) - stocktitan.net

Mar 22, 2026
pulisher
Mar 21, 2026

BRX Technical Analysis & Price Forecast - intellectia.ai

Mar 21, 2026
pulisher
Mar 21, 2026

EVSB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

EVSB PE Ratio & Valuation, Is EVSB Overvalued - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

AHH Technical Analysis & Price Forecast - intellectia.ai

Mar 21, 2026
pulisher
Mar 21, 2026

ALDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

GARP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

FIBK Technical Analysis & Price Forecast - intellectia.ai

Mar 21, 2026
pulisher
Mar 21, 2026

NAT Technical Analysis & Price Forecast - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

DALN Technical Analysis & Price Forecast - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

WASH.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

TRVI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026
pulisher
Mar 21, 2026

Returns Recap: Can Grace Therapeutics Inc maintain sales growth2026 Trade Ideas & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Why is Grace Therapeutics Inc stock going up2026 Momentum Check & AI Powered Market Entry Ideas - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 20, 2026

HLIT Technical Analysis & Price Forecast - Intellectia AI

Mar 20, 2026
pulisher
Mar 19, 2026

IXHL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 19, 2026
pulisher
Mar 19, 2026

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences - The Manila Times

Mar 19, 2026
pulisher
Mar 19, 2026

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease - The Manila Times

Mar 19, 2026
pulisher
Mar 19, 2026

Why some brain bleed patients miss full doses takes center stage at 2 meetings - Stock Titan

Mar 19, 2026
pulisher
Mar 19, 2026

RGNX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 19, 2026
pulisher
Mar 13, 2026

Market Trends: Is KIMPRN a play on infrastructure spending2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn

Mar 13, 2026
pulisher
Mar 13, 2026

Traumatic Brain Injury Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Lab - Barchart

Mar 13, 2026
pulisher
Mar 10, 2026

Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat

Mar 10, 2026
pulisher
Mar 07, 2026

Is Grace Therapeutics Inc. stock positioned for digital transformation2025 Trade Ideas & AI Forecasted Entry and Exit Points - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Aug Selloffs: What is the cash position of Willis Lease Finance Corporation2025 Short Interest & Technical Confirmation Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Aug Patterns: Will Haoxin Holdings Limited stock outperform Nasdaq indexTrend Reversal & Weekly Watchlist for Hot Stocks - Naître et grandir

Mar 06, 2026
pulisher
Mar 06, 2026

Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica

Mar 06, 2026
pulisher
Mar 06, 2026

Aug Momentum: Is now the right time to enter SAIA2025 AllTime Highs & Low Risk High Win Rate Picks - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

GRCE SEC FilingsGrace Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

GRCE: IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment - TradingView

Mar 04, 2026
pulisher
Mar 03, 2026

Institution Moves: What is Grace Therapeutics Incs valuation compared to sector2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn

Mar 03, 2026
pulisher
Mar 01, 2026

Is OXLC.G forming a breakout patternPortfolio Performance Report & Free Daily Entry Point Trade Alerts - mfd.ru

Mar 01, 2026
pulisher
Mar 01, 2026

Rate Hike: Can Grace Therapeutics Inc weather a recessionProfit Target & Reliable Price Action Trade Plans - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

ANTX PE Ratio & Valuation, Is ANTX Overvalued - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI

Feb 27, 2026

Grace Therapeutics Inc Azioni (GRCE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):